Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1975-11-26
1977-02-01
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
260243C, 260326R, 260475SC, 260 4PS, C07D50124, C07D50132
Patent
active
040062309
ABSTRACT:
Novel antibacterial agents; namely, 7-(.alpha.-acylamino-arylacetamido)-cephalosporanic acid derivatives having the formula: ##STR1## wherein R.sup.1 is thienyl, 2-furyl, phenyl, substituted thienyl or substituted phenyl; R is hydroxyl; R.sup.2 is hydrogen, hydroxy, acetoxy, carbamoyloxy, N-pyridyl, azido or heterocyclic thio group; R and R.sup.2 when taken together represent an oxygen atom; R.sup.3 is sulpho or COOR.sup.4.sup.' wherein R.sup.4.sup.' is hydrogen or R.sup.4 wherein R.sup.4 is lower alkyl, 5-indanyl, naphthyl, phenyl, or substituted phenyl, CONR.sup.5 R.sup.6, wherein each of R.sup.5 and R.sup.6 is hydrogen, lower alkyl or cycloalkyl; or R.sup.5 and R.sup.6 together with the nitrogen atom to which they are attached form a saturated heterocyclic group; X is oxygen or sulphur, a direct link, carbonyl, methylene, hydroxymethylene, sulphinyl, sulphonyl or an imino group of the formula --NR.sup.7 --, wherein R.sup.7 is hydrogen, lower alkyl, lower alkenyl, or benzyl; and each of alk.sup.1 and alk.sup.2 is a divalent saturated aliphatic hydrocarbon group containing from 1 to 3 carbon atoms; the pharmaceutically acceptable salts thereof, and methods for their preparation.
REFERENCES:
patent: 3341532 (1967-09-01), Lewis et al.
Heusler et al., "Chemical Abstracts," 23-12-71, vol. 76, p. 460, Abst. No. 99691e.
Cox David A.
Shroot Braham
Pfizer Inc.
Rizzo Nicholas S.
Wheeler David E.
LandOfFree
7-D-(.alpha.-acylamino-arylacetamido)-cephalosporanic acid deriv does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-D-(.alpha.-acylamino-arylacetamido)-cephalosporanic acid deriv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-D-(.alpha.-acylamino-arylacetamido)-cephalosporanic acid deriv will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1091764